Multiple sclerosis - Therapeutic update

Therapy for multiple sclerosis (MS) is undergoing rapid changes. We discuss recent developments in the therapy of MS, failures as well as successes, a nd consider some newer approaches. Multiple sclerosis, a multifocal, initia lly remitting-relapsing, and in some cases primarily progressive, inflammat ory central nervous system immune-mediated demyelinating disease, with some axonal involvement, is currently the most common disabling neurologic dise ase of young people in North America and Europe. Although much is known abo ut the pathogenesis, there is no cure and the disease must be managed long- term. Recently, there have been a number of advances in the treatment of MS .